吉利德科技

GILD NASDAQ
65.04
-2.17
-3.23%
盘后: 65.10 +0.06 +0.09% 19:56 07/19 EDT
开盘
67.52
昨收
67.21
最高
67.53
最低
64.91
成交量
887.64万
成交均量(3M)
641.96万
52周最高
79.61
52周最低
60.32
换手率
0.70%
市值
827.02亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供吉利德科技 GILD股票价格,吉利德科技股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.
展开 >

最近浏览

名称
价格
涨跌幅